Clinical efficacy of clozapine in treatment-refractory schizophrenic patients

Author： Min-Soo L.   In-Kwa J.   Dong-Il K.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 342-342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of clozapine on plasma monoamine metabolites in treatment-refractory schizophrenic patients

By Min-Soo L.   Seung-Hyun K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 341-342

Elsevier

Access to resources Recommend Favorite

Steady-state Pharmacokinetics of Clozapine in Refractory Schizophrenic Saudi Arabian Patients

By Hussein R.   Gad A.   Raines D.A.   Chaleby K.   Al-Rawithi S.   El-Yazigi A.  

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 7, 1999-07 ,pp. : 473-478

Pharmaceutical Press

Access to resources Recommend Favorite

Treatment-refractory bipolar disorder: classification to aid in clinical management

By Gajwani Prashant  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 12, 2009-08 ,pp. : 1907-1915

Informa Healthcare

Access to resources Recommend Favorite

Infliximab induced remission in five patients with treatment-refractory Wegener's granulomatosis

By  

Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

What is an Adequate Trial with Clozapine?: Therapeutic Drug Monitoring and Time to Response in Treatment-Refractory Schizophrenia

By Schulte Peter F.J.  

Clinical Pharmacokinetics, Vol. 42, Iss. 7, 2003-01 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite